Risk of Bowel Perforation in Patients Receiving Interleukin-2 After Therapy With Anti-CTLA 4 Monoclonal Antibody
- 1 January 2007
- journal article
- letter
- Published by Wolters Kluwer Health in Journal of Immunotherapy
- Vol. 30 (1) , 130
- https://doi.org/10.1097/01.cji.0000211334.06762.89
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- Enterocolitis in Patients With Cancer After Antibody Blockade of Cytotoxic T-Lymphocyte–Associated Antigen 4Journal of Clinical Oncology, 2006
- Gastrointestinal Perforations Associated With Interleukin-2 AdministrationJournal of Immunotherapy, 2004